These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34659499)

  • 21. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers.
    Algorta J; Andrade L; Medina M; Kirkov V; Arsova S; Li F; Chi J
    Clin Drug Investig; 2016 Sep; 36(9):753-762. PubMed ID: 27470430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses.
    Coates MS; Fletcher DF; Chan HK; Raper JA
    Pharm Res; 2005 Jun; 22(6):923-32. PubMed ID: 15948036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Physico-mechanical Properties and Electrostatic Charging Behavior of Different Capsule Types for Inhalation Under Distinct Environmental Conditions.
    Pinto JT; Wutscher T; Stankovic-Brandl M; Zellnitz S; Biserni S; Mercandelli A; Kobler M; Buttini F; Andrade L; Daza V; Ecenarro S; Canalejas L; Paudel A
    AAPS PharmSciTech; 2020 May; 21(4):128. PubMed ID: 32399597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults.
    Delvadia R; Hindle M; Longest PW; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):138-44. PubMed ID: 22947131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of capsule dosing techniques for use in dry powder inhalers.
    Edwards D
    Ther Deliv; 2010 Jul; 1(1):195-201. PubMed ID: 22816126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel approach for real-time monitoring of carrier-based DPIs delivery process
    Zhang X; Cui Y; Liang R; Wang G; Yue X; Zhao Z; Huang Z; Huang Y; Geng J; Pan X; Wu C
    Acta Pharm Sin B; 2020 Jul; 10(7):1331-1346. PubMed ID: 32874832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an Inline Dry Powder Inhaler That Requires Low Air Volume.
    Farkas D; Hindle M; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2018 Aug; 31(4):255-265. PubMed ID: 29261454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier.
    Iida K; Hayakawa Y; Okamoto H; Danjo K; Leuenberger H
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1326-30. PubMed ID: 11605663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical tools and control of internal lubricant content of inhalation grade HPMC capsules during manufacture.
    Ayala G; Díez F; Gassó MT; Jones BE; Martín-Portugués R; Ramiro-Aparicio J
    Int J Pharm; 2016 Apr; 503(1-2):36-40. PubMed ID: 26899981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
    Wu X; Zhang W; Hayes D; Mansour HM
    Int J Nanomedicine; 2013; 8():1269-83. PubMed ID: 23569375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Electrostatic Behavior of Dry Powder-Inhaled Model Formulations.
    Jetzer MW; Morrical BD
    J Pharm Sci; 2019 Sep; 108(9):2949-2963. PubMed ID: 31004652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses.
    Coates MS; Chan HK; Fletcher DF; Raper JA
    Pharm Res; 2005 Sep; 22(9):1445-53. PubMed ID: 16132356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
    Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
    Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator.
    Hira D; Okuda T; Mizutani A; Tomida N; Okamoto H
    J Pharm Sci; 2018 Jun; 107(6):1731-1735. PubMed ID: 29428382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements.
    Magramane S; Vlahović K; Gordon P; Kállai-Szabó N; Zelkó R; Antal I; Farkas D
    Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.